Japan Pancreatic Cancer Registry; 30th Year Anniversary: Japan Pancreas Society
Explore this paper's citation graph
Summary
The improvement of survival of patients with invasive cancer in Japan can be attributed to the introduction of effective chemotherapies, regionalization, and the earlier diagnosis and treatment.
- Type
- article
- Published
- 2012-10-01
- Cited by
- 368
- References
- 30
- OpenAlex
- https://openalex.org/W22750974
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:40996341
Keywords
Compliance (psychology), Quality (philosophy), Medicine, Quality management, Medical education
References
- FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
- Tumor size as a predictive factor
- Trends in treatment for pancreatic cancer.
- Progression model for pancreatic cancer.
- Japan Pancreatic Cancer Registry: current status.
- Clinicopathological Aspects of Small Pancreatic Cancer
- Pancreatic Cancer Registry in Japan: 20 Years of Experience
- An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms
- R0 resection for ductal pancreatic cancer—Japanese experience
- Ras Activity Levels Control the Development of Pancreatic Diseases
- Pancreatic Ductal Adenocarcinoma Derived From IPMN and Pancreatic Ductal Adenocarcinoma Concomitant With IPMN
- EBM-based Clinical Guidelines for Pancreatic Cancer 2009 from the Japan Pancreas Society: a synopsis.
- Pancreatic cancer: current status of treatment and survival of 16 071 patients diagnosed from 1981–1996, using the Japanese National Pancreatic Cancer Database
- Current Status of Surgery for Pancreatic Cancer
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
- CA19‐9 as a Screening and Diagnostic Tool in Symptomatic Patients: The Japanese Experience
- International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas
- Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
- Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
- Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial
Cited by
- Genetic assessment of recurrent pancreatic high‐risk lesions in the remnant pancreas: Metachronous multifocal lesion or local recurrence?☆
- Detecting Early Pancreatic Cancer: Current Problems and Future Prospects
- Expression and Significances of MTSS1 in Pancreatic Cancer
- Describing Patterns of Care in Pancreatic Cancer: A Population-Based Study
- Efficacy of repeated cytology of pancreatic juice obtained by endoscopic nasopancreatic drainage tube for early diagnosis of pancreatic cancer: a case series including a case of carcinoma in situ
- Screening for Pancreatic Cancer.
- Effective screening for early diagnosis of pancreatic cancer.
- Predictors and Diagnostic Strategies for Early-Stage Pancreatic Ductal Adenocarcinoma: A Retrospective Study
- Glucose intolerance and the risk of pancreatic cancer
- Applications of Nanotechnology in the Management of Cancer: Miniature Technology, Great Potential.
- Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells
- Multifunctional gadolinium-labeled silica-coated Fe3O4 and CuInS2 nanoparticles as a platform for in vivo tri-modality magnetic resonance and fluorescence imaging.
- Relationship between autoimmune pancreatitis and pancreatic cancer: a single-center experience.
- Maximum Standardized Uptake Value on 18F-Fluoro-2-Deoxy-Glucose Positron Emission Tomography/Computed Tomography and Glucose Transporter-1 Expression Correlates With Survival in Invasive Ductal Carcinoma of the Pancreas
- Importance of resectability status in neoadjuvant treatment for pancreatic cancer
- Inflammation and pancreatic cancer: disease promoter and new therapeutic target
- The role of ERCP in the era of EUS-FNA for preoperative cytological confirmation of resectable pancreatic ductal adenocarcinoma
- Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer.
- Clinical importance of Familial Pancreatic Cancer Registry in Japan: a report from kick-off meeting at International Symposium on Pancreas Cancer 2012
- Strategies for early detection of resectable pancreatic cancer.
Related papers
- Building Healthy Workplace Environments Through Collaborative Care Councils
- An evaluation of an Australian initiative designed to improve interdisciplinary collaboration in primary mental health care.
- Do we need more training for interdisciplinary and interprofessional collaboration prior to implementing any primary care research action
- Partnering for Prevention: A Pressure Ulcer Prevention Collaborative Project
- The depression initiative: implementation of an adapted impact collaborative care model in the primary care setting in the Netherlands
- A Framework to Harness the Power of Quality Collaboratives to Improve Perinatal Outcomes
- Challenges to collaborative practice in the aged care setting
- The Establishing Focus protocol: Training for collaborative agenda setting and time management in the medical interview.